Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Recent blog posts
Latest Hotspot
8 min read
FPR3 Biologics Sequence Review Report 2026: N-formyl peptide receptor 3 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FPR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FSHR Biologics Sequence Review Report 2026: Follicle-stimulating hormone receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FSHR protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FPR2 Biologics Sequence Review Report 2026: N-formyl peptide receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FPR2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
EDNRB Biologics Sequence Review Report 2026: Endothelin receptor type B Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of EDNRB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
F2RL1 Biologics Sequence Review Report 2026: Proteinase-activated receptor 2 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of F2RL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
FCGRT Biologics Sequence Review Report 2026: IgG receptor FcRn large subunit p51 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of FCGRT protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
F2R Biologics Sequence Review Report 2026: Proteinase-activated receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of F2R protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
DRD3 Biologics Sequence Review Report 2026: D(3) dopamine receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of DRD3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
DRD5 Biologics Sequence Review Report 2026: D(1B) dopamine receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of DRD5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
DRD2 Biologics Sequence Review Report 2026: D(2) dopamine receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of DRD2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
DRD4 Biologics Sequence Review Report 2026: D(4) dopamine receptor Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of DRD4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CRHR1 Biologics Sequence Review Report 2026: Corticotropin-releasing hormone receptor 1 Similarity and Patent-Risk Signals
18 August 2026
A Biology Modality MCP review of CRHR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
12
13
14
15
16
>>
1103
>